skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Found 872 results for your search:
Total relevant funding to Leukemia for this search:
$227,025,963
Fiscal Year FY 2011
Cancer Type [Leukemia]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 872 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
"BCR/ABL-PI-3k-ROS pathway induce genomic instability ...." 5R01CA134458-02 $307,951 $307,951 SKORSKI, TOMASZ TEMPLE UNIVERSITY
2
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia??? 1R01CA158275-01A1 $326,488 $326,488 Crooks, Peter UNIVERSITY OF KENTUCKY
3
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $213,606 $85,442 Rothman, Nat DCEG (NCI)
4
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOMA ZIA CP010121-10363 $17,250 $17,250 Lan, Qing DCEG (NCI)
5
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia 1R21CA161436-01 $207,634 $207,634 Liang, Chengyu UNIVERSITY OF SOUTHERN CALIFORNIA
6
A Novel Screen for Compounds that Outflank BCR-ABL Drug-Resistance 5R01CA136699-03 $305,910 $305,910 COLICELLI, JOHN UNIVERSITY OF CALIFORNIA LOS ANGELES
7
A Novel sequencing-based approach to discovering rare genetic factors for ALL. 5K08CA140720-02 $149,387 $149,387 Druley, Todd WASHINGTON UNIVERSITY
8
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC 5R01CA129974-05 $315,153 $315,153 LETAI, ANTHONY DANA-FARBER CANCER INSTITUTE
9
A Phase I/II Trial of Eltrombopag in Elderly Acute Myeloid Leukemia Patients 5R21CA153018-02 $322,040 $322,040 Carroll, Martin UNIVERSITY OF PENNSYLVANIA
10
A Phase II proof-of-concept trial to study kinase inhibition in relapsed/refracto 1R21CA159265-01 $272,667 $272,667 LORIAUX, MARC OREGON HEALTH AND SCIENCE UNIVERSITY
11
A Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL 1R21CA161688-01 $360,330 $360,330 Burke, Michael UNIVERSITY OF MINNESOTA TWIN CITIES
12
A Role for KSHV in the Pathogenesis of Malignancies ZIA SC 010356 $370,199 $37,019 Tosato, Giovanna CCR (NCI)
13
A Role for PML in Genome Stability and DNA Damage Response 5R01CA055577-18 $256,139 $204,911 CHANG, KUN-SANG UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
14
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,178,242 $58,912 Sinha, Rashmi DCEG (NCI)
15
Aberrant activation of HGF/MET signaling as a therapeutic target in AML 1K08CA160660-01 $156,330 $156,330 Kentsis, Alex DANA-FARBER CANCER INSTITUTE
16
Abramson Cancer Center Support Grant 2P30CA016520-35 $7,696,742 $538,772 LERMAN, CARYN UNIVERSITY OF PENNSYLVANIA
17
Abramson Cancer Center Support Grant 3P30CA016520-35S1 $50,000 $3,500 LERMAN, CARYN UNIVERSITY OF PENNSYLVANIA
18
Academic Training in Medical Oncology 3T32CA009297-28S1 $66,919 $6,692 RIBAS, ANTONI UNIVERSITY OF CALIFORNIA LOS ANGELES
19
Academic Training in Medical Oncology 5T32CA009297-28 $316,308 $31,631 RIBAS, ANTONI UNIVERSITY OF CALIFORNIA LOS ANGELES
20
Activation of Proto-Oncogenes by Chromosomal Translocation ZIA SC 010378 $328,740 $164,369 Aplan, Peter CCR (NCI)
21
Adoptive immunotherapy after umbilical cord blood transplant 5R01CA124782-05 $283,822 $283,822 COOPER, LAURENCE UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
22
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells 5R01CA138738-03 $381,617 $381,617 Brentjens, Renier SLOAN-KETTERING INSTITUTE FOR CANCER RES
23
Adoptive T-Cell Therapy for Acute Leukemia 5R21CA132277-02 $310,970 $310,970 BALL, EDWARD UNIVERSITY OF CALIFORNIA SAN DIEGO
24
Adult Leukemia Research Center 5P01CA018029-36 $5,431,018 $5,431,018 APPELBAUM, FREDERICK FRED HUTCHINSON CANCER RESEARCH CENTER
25
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture ZIA CP010119-10527 $347,286 $173,642 Alavanja, Michael DCEG (NCI)
26
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia 5R01CA139032-03 $322,040 $322,040 Muschen, Markus CHILDREN'S HOSPITAL LOS ANGELES
27
ALL therapy and developing brains: MRI measures, genetic factors and cognition 2R01CA090246-06A2 $380,224 $380,224 REDDICK, WILBURN ST. JUDE CHILDREN'S RESEARCH HOSPITAL
28
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi 1K23CA154532-01 $169,590 $169,590 Bleakley, Marie FRED HUTCHINSON CANCER RESEARCH CENTER
29
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $58,058 $38,899 Kochenderfer, James CCR (NCI)
30
Alloreactive Regulatory T cells control GVHD and maintain GVL effect 2R01CA118116-04A1 $291,425 $291,425 YU, XUE-ZHONG H. LEE MOFFITT CANCER CTR & RES INST
31
Altered Glycolytic Pathway in in vitro Models of leukemia developed in hypoxia 1R15CA159308-01 $444,394 $444,394 Kang, Min TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
32
Analysis of higher order chromatin structures in normal and cancer epigenomes 5R01CA140485-02 $333,111 $333,111 Kim, Tae Hoon YALE UNIVERSITY
33
Analysis of the leukemic stem cell niche in chronic myeloid leukemia 5K08CA138916-02 $160,016 $160,016 Krause, Daniela MASSACHUSETTS GENERAL HOSPITAL
34
Anatomic Pathology Residency Program ZIE BC 011384 $1,179,485 $58,974 Oberholtzer, J. CCR (NCI)
35
Animal models to study the role of INK4b loss in human acute myeloid leukemia ZIA BC 011027 $721,379 $721,378 Wolff, Linda CCR (NCI)
36
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies ZIA BC 010647 $388,021 $194,010 Rader, Christoph CCR (NCI)
37
Antibody V Gene Expression B Cell Lymphocytic Leukemia 5R37CA049870-24 $322,228 $322,228 KIPPS, THOMAS UNIVERSITY OF CALIFORNIA SAN DIEGO
38
Antileukemic effort of NK cells in HCT for pediatric AML 5R01CA120583-05 $347,302 $347,302 LEUNG, WING ST. JUDE CHILDREN'S RESEARCH HOSPITAL
39
Antitumor-Antibiotics from Marine Microorganisms 5R37CA044848-25 $373,010 $149,204 FENICAL, WILLIAM UNIVERSITY OF CALIFORNIA SAN DIEGO
40
Apoptosis Induced by Glucocorticoids and MEK1/2 Inhibitors in Leukemia 4R01CA134473-03 $237,412 $237,412 HARADA, HISASHI VIRGINIA COMMONWEALTH UNIVERSITY
41
Application of 454 Sequencing to Cancer Epigenomics 5R33CA134304-03 $305,392 $305,392 SHI, HUIDONG GEORGIA HEALTH SCIENCES UNIV RES INSTIT
42
Aptamer Based Technology for Molecular Analysis of Leukemia 5R01CA129311-04 $294,868 $294,868 Li, Ying UNIVERSITY OF FLORIDA
43
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-33S1 $139,575 $2,792 Alberts, David UNIVERSITY OF ARIZONA
44
Arizona Cancer Center-Cancer Center Support Grant 3P30CA023074-33S2 $75,000 $1,500 Alberts, David UNIVERSITY OF ARIZONA
45
Arizona Cancer Center-Cancer Center Support Grant 5P30CA023074-33 $3,953,813 $79,076 Alberts, David UNIVERSITY OF ARIZONA
46
Arsenic Trioxide and Acute Myeloid Leukemia 5R01CA093533-08 $247,445 $247,445 JING, YONGKUI MOUNT SINAI SCHOOL OF MEDICINE
47
Assays for Screening Histone Modifications in Cancer 5R01CA107106-06 $226,740 $226,740 FREITAS, MICHAEL OHIO STATE UNIVERSITY
48
ATBC Study ZIA CP010195-03031 $828,679 $24,860 Albanes, Demetrius DCEG (NCI)
49
Augmenting Antitumor Immunity after Allografting 5R01CA122779-04 $281,662 $281,662 LUZNIK, LEO JOHNS HOPKINS UNIVERSITY
50
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011413 $116,117 $58,058 Kochenderfer, James CCR (NCI)
Total relevant funding to Leukemia for this search: $227,025,963
Showing 1 - 50 of 872 results
Go to top